A revolution in treatment of HFrEF with a SGLT2 inhibitor

5' education - Sep. 1, 2019 - Paris, France - Prof. Subodh Verma, MD, PhD - Toronto, ON, Canada

Educational information

This video was recorded at ESC 2019 in Paris, France, on September 1, 2019.

Faculty

Prof. Subodh Verma, MD, PhD is a cardiac surgeon‐scientist at St Michael’s Hospital in Toronto and Professor at the University of Toronto. He is a trained pharmacist with a PhD in cardiovascular pharmacology from the University of British Columbia.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the DAPA-HF study

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.